Cite
HARVARD Citation
Ray, K. et al. (n.d.). Apabetalone, a selective BET protein inhibitor, reduces ischemic cardiovascular events and hospitalization for heart failure in patients with acute coronary syndrome and type 2 diabetes. European heart journal. p. . [Online].